NHS priorities

Whether it’s to prepare for the next Pharmacy Quality Scheme deadline, or to increase your confidence in helping people with a learning disability, this section provides topic-specific pages that link to current NHS priorities. This section will support you in keeping your knowledge and skills up to date in order to provide high-quality pharmacy services and be service-ready.

Clinical pharmacy

Our clinical portfolio is expanding on a frequent basis, helping you to advance your knowledge and skills and deliver medicines optimisation in practice for all sectors of pharmacy. From two new focal points a year to our small group learning for hospital pharmacists – Optimise – this section focuses on clinical pharmacy, diseases and therapeutics.

Public health

The public health agenda is embedded in pharmacy, yet topics such as emergency contraception or stop smoking support are as prevalent as ever. As well as our public health workshops, use this section to access a wide range of resources to assure and maintain your competence, all underpinned by the Declaration of Competence system.

Familial hypercholesterolaemia: supporting people better focal point now available

We are pleased to announce that our Familial hypercholesterolaemia: supporting people better focal point is now open for booking.

People who have familial hypercholesterolemia have a higher risk of heart disease and death at a younger age. The NHS Long Term Plan aims for 25% of people with familial hypercholesterolaemia to be identified over the next 5 years.

This focal point learning programme aims to increase your awareness of familial hypercholesterolaemia to enable you to identify, manage and educate patients who are living with the condition. You will consider how familial hypercholesterolemia differs from high cholesterol in the general population, and how you can support patients to reduce the risk of cardiovascular disease (CVD) and improve health outcomes.

In addition, we will consider how to discuss the condition and its impact on cardiovascular risk in a sensitive and person-centred way, and how to describe the range of treatment options available to patients with familial hypercholesterolaemia to promote shared decision making.

For more information, please visit:


All news stories